Master Pharmacy (605)
(GZ.52.355/11-VII/D/2/2002, ab WS 02/03)
M1 (Bio)pharmaceuticals with Effect on Metabolic Disorders and Impaired Organ- and System Functions (10 ECTS)
M2 Antiinfectives, Antineoplastic Drugs and (bio)pharmaceuticals with Effect on the Immune System (10 ECTS)
M3 Production of Magistral Formulae (10 ECTS)
-
Klang, Mo 13:15-14:45 (2×), Fr 14.03. 13:15-14:45, We 19.03. 13:15-14:45
-
Klang
-
Klang
M4 (Bio)pharmaceuticals with Effect on the Cardiovascular System (8 ECTS)
- EXAM (Bio)pharmaceuticals with Effect on the Cardiovascular System - M4
-
Langer, Mo 08:00-09:30 (6×), Tu 08:00-09:30 (6×), We 08:00-09:30 (5×), Th 08:00-09:30 (6×), Fr 08:00-09:30 (6×)
M5 (Bio)pharmaceuticals with Effect on the Nervous System (7 ECTS)
- EXAM (Bio)pharmaceuticals with Effect on the Nervous System - M5
-
Ecker, Mo 08:00-09:30 (6×), Tu 08:00-09:30 (6×), We 08:00-09:30 (6×), Fr 08:00-09:30 (6×), Th 08:00-09:30 (4×)
M6 Pharmaceutical Technology and Biopharmaceutics for Master Students (6 ECTS)
-
Lächelt, Mo 09:45-11:15 (11×), Tu 09:45-11:15 (11×), We 09:45-11:15 (11×)
M7 Selected Chapters of Pharmaceutical Technology and Biopharmaceutics (4 ECTS)
-
Gabor
-
322075 VU 1 ECTS Selected Chapters of Pharmaceutical Technology and Biopharmaceutics - MA8 - M7 - (2 Kurse)Klang
-
Harvey
-
Hädrich
-
Rademacher, Th 09:45-11:15 (2×), Th 26.06. 13:15-14:45
-
Dailey, Fr 28.03. 11:30-13:00, Fr 11.04. 09:45-11:15, Tu 13.05. 13:15-14:45
M8 Quality Control of Herbal Medicinal Products (5 ECTS)
-
Ortmayr
-
Ortmayr
M9 Medication Therapy Management and Public Health (10 ECTS)
- EXAM Metabolism, Drug Interactions and personalized Pharmacotherapy - MA10/ MA11 - M9
-
Kopp, Mo 11:30-13:00 (3×), Tu 11:30-13:00 (4×), We 15:00-16:30 (3×), Th 15:00-16:30 (2×), Mo 02.06. 15:00-16:30
-
Kamyar, We 08:00-09:30 (3×), Th 13.03. 08:00-09:30, We 09:45-11:15 (10×)
-
Kampleitner, Mo 16:45-18:15 (4×), Mo 08:00-13:00 (3×), Mo 16:45-20:00 (3×)
-
Kamyar, Tu 16:45-20:00 (12×), Th 16:45-20:00 (10×), Fr 04.04. 16:45-20:00, Tu 13:15-18:15 (2×)
M10 Evidence Based Pharmacy (5 ECTS)
- EXAM Introduction to Evidence Based Pharmacy - MA14 - M10
-
Kamyar, Mo 16:45-18:15 (3×), Tu 04.03. 09:45-11:15, We 05.03. 16:45-18:15, Th 06.03. 08:00-09:30, Tu 11.03. 08:00-09:30, Th 13.03. 09:45-11:15
-
Kamyar, Fr 27.06. 16:45-20:00
-
Kamyar, Tu 09:45-11:15 (10×), Tu 10.06. 08:00-09:30
M11 Clinical Pharmacy and Pharmacoepidemiology (10 ECTS)
- EXAM VO Clinical Pharmacy and Chemical Diagnostics - MA17/ MA18 - M11
-
Kopp, Th 15:00-16:30 (2×), Fr 15:00-16:30 (2×), Mo 17.03. 15:00-16:30, Tu 18.03. 15:00-16:30, We 19.03. 15:00-16:30
-
Stappen, Mo 15:00-16:30 (2×), Tu 15:00-16:30 (2×), We 05.03. 15:00-16:30, Th 06.03. 15:00-16:30, Fr 07.03. 15:00-16:30
-
Stappen, Mo 15:00-16:30 (2×), Tu 15:00-16:30 (2×), We 15:00-16:30 (2×), Th 15:00-16:30 (2×), Fr 15:00-16:30 (2×)
-
Stappen
-
Stappen
M12 Law for Pharmacists (2 ECTS)
M13 Selected Chaptures of Pharmaceutical Research (3 ECTS)
-
Langer
-
Schmidt
-
Dirsch
-
Dailey
M14 Additional Qualifications and Scientific Specialization (5 ECTS)
-
322050 VU 1 ECTS Special strategies for the structure elucidation of drugs and natural products by NMR - M14Grienke
-
Ogris
-
Pichler
-
Krist
-
Khom-Steinkellner, Tu 15:00-16:30 (2×), We 07.05. 15:00-16:30, Th 08.05. 15:00-16:30, We 13:15-14:45 (2×), Th 15.05. 13:15-14:45, Th 22.05. 11:30-13:00
-
Glasl-Tazreiter
-
Zotchev
-
Stöger
-
Glasl-Tazreiter
-
Gabor
-
322075 VU 1 ECTS Selected Chapters of Pharmaceutical Technology and Biopharmaceutics - MA8 - M7 - (2 Kurse)Klang
-
Studenik
-
322085 VU 1 ECTS Advances in the Treatment of Cognitive Aging - M14 - relevant aspects for pharmacistsKhom-Steinkellner
-
322087 VO 1 ECTS 3R (Replacement-Reduction-Refinement)-Konzepte für den optimierten Einsatz von Tierversuchen - M14Zille
-
Glasl-Tazreiter
-
Dailey
-
Harvey
-
Hädrich
-
Rademacher, Th 09:45-11:15 (2×), Th 26.06. 13:15-14:45
-
Dailey, Fr 28.03. 11:30-13:00, Fr 11.04. 09:45-11:15, Tu 13.05. 13:15-14:45
Last modified: Fr 10.01.2025 00:44